When is spinal pain "neuropathic"?

Orthopedic Clinics of North America

Volumn 35, Issue 1, 2004, Pages 73-84

  Gorman, David J ^a   Kam, Peter A ^a   Brisby, Helena ^a   Diwan, Ashish D ^a  

^a ST GEORGE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BACLOFEN; BENSERAZIDE PLUS LEVODOPA; CAPSAICIN; CARBAMAZEPINE; CITALOPRAM; DEXTROMETHORPHAN; FLUOXETINE; GABAPENTIN; LEVODOPA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OPIATE; OXYCODONE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRAMADOL;

CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DYSESTHESIA; ELECTROENCEPHALOGRAM; HUMAN; HYPERALGESIA; NERVE CELL PLASTICITY; NEUROPATHIC PAIN; NEUROTRANSMISSION; NOCICEPTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN ASSESSMENT; PARESTHESIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SIDE EFFECT; SPINAL CORD; SPINAL PAIN; SYMPTOM; TREATMENT OUTCOME;

EID: 0742285256     PISSN: 00305898     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0030-5898(03)00098-1     Document Type: Review

References (40)

1. Selim A.J., Ren X.S., Fincke G.et al. The importance of radiating leg pain in assessing health outcomes among patients with low back pain. Spine. 23:1998;470-474.
2. Woolf C.J., Bennett G.J., Doherty M.et al. Towards a mechanism-based classification of pain. Pain. 77:1998;227-229.
3. Brisby H. Nerve root injuries in patients with low back pain. Orthop Clin N Am. 34:2003;221-230.
4. Jensen T.S., Baron R. Translation of symptoms and signs into mechanisms in neuropathic pain. Pain. 102:2003;1-8.
5. Waddell G. A new clinical model for the treatment of low back pain. Spine. 12:1987;632-644.
6. Haldeman S. Presidential address, North American Spine Society: failure of the pathology model to predict back pain. Spine. 15:1990;718-724.
7. Deyo R.A., Weinstein J.N. Low back pain. N Engl J Med. 344:2003;363-370.
8. Pang W.W., Mok L.S., Lin M.L.et al. Application of spinal pain mapping in the diagnosis of low back pain - analysis of 104 cases. Acta Anaesthesiol Sin. 36:1998;71-74.
9. Merskey H., Bogduk N. Classification of chronic pain: descriptors of chronic pain syndromes and definitions of pain terms. 1994;IASP Press, Seattle.
10. Melzack R., Wall P.D. Pain mechanisms: a new theory. Science. 150:1965;971.
11. Woolf C.J., Salter M.W. Neuronal plasticity: increasing the gain in pain. Science. 288:2000;1765-1768.
12. Dickenson A.H. A cure for wind up: NMDA receptor antagonists as potential analgesics. Trends Pharmacol Sci. 11:1990;307-309.
13. Watkins L.R., Milligan E.D., Maier S.F. Spinal cord glia: new players in pain. Pain. 93:2001;201-205.
14. Manchikanti L., Staats P.S., Singh V.et al. Evidence-based practice guidelines for interventional techniques in the management of chronic spinal pain. Pain Phys. 6:2003;3-81.
15. Manchikanti L., Singh V., Pampati V.et al. Evaluation of the relative contributions of various structures in chronic low back pain. Pain Phys. 4:2001;308-316.
16. Lord S.M., Barnsley L., Bogduk N. The utility of comparative local anaesthetic blocks versus placebo-controlled blocks for the diagnosis of cervical zygapophysial joint pain. Clin J Pain. 11:1995;208-213.
17. Otto M., Bak S., Bach F.W., Jensen T.S., Sindrup S.H. Pain phenomena and possible mechanisms in patients with painful polyneuropathy. Pain. 101:2003;187-192.
18. Moulin D.E. Neuropathic cancer pain: syndromes and clinical controversies. Portenoy R.K. Topics in palliative care. Vol. 2:1998;7-29 Oxford University Press, New York.
19. Galer B.S., Jensen M.P. Development and preliminary validation of a pain measure specific to neuropathic pain. The neuropathic pain scale. Neurology. 48:1997;332-338.
20. Bennett M. The LANSS pain scale; the Leeds assessment of neuropathic symptoms and signs. Pain. 92:2001;147-157.
21. Casey K.L. The imaging of pain: background and rationale. Bushnell M.C. Pain imaging. Vol. 18:2000;1-29 IASP Press, Seattle.
22. Flor H., Elbert K.S.K. Phantom-limb pain as a perceptual correlate of cortical reorganisation following arm amputation. Nature. 375:1995;482-484.
23. Sindrup S.H., Jensen T.S. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain. 83:1999;389-400.
24. Cook R.J., Sackett D.L. The number needed to treat: a clinically useful method of treatment effect. BMJ. 310:1995;452-454.
25. McQuay H.J., Moore R.A. An evidence based resource for pain relief. 1998;Oxford University Press, Oxford.
26. Watson C.P.N., Babul N. Efficacy of oxycodone in neuropathic pain: a randomised trial in post-herpetic neuralgia. Neurology. 50:1998;1837-1841.
27. Gimbel J.S., Richards P., Portenoy R.K. Controlled release oxycodone for pain in diabetic neuropathy: a randomised controlled trial. Neurology. 60:2003;927-934.
28. Rowbotham M.C., Reisner-Keller L.A., Fields H.L. Both intravenous lidocaine and morphine reduce pain of post-herpetic neuralgia. Neurology. 41:1991;1024-1028.
29. Gourlay G.K. Different opioids - same actions? Kalso E., McQuay H.J., Weisenfeld-Hallin Z. Opioid sensitivity of chronic non-cancer pain. Progress in pain research and management. Vol. 14:1999;97-115 IASP Press, Seattle.
30. Ebert B., Andersen S., Krogsgaard-Larsen P. Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord. Neurosci Lett. 187:1995;165-168.
31. Kalso E. Opioids for chronic noncancer pain. Dostrovsky J.O., Carr D.B., Koltzenberg M. Proceedings of the 10th World Congress on Pain. Progress in pain research and management. Vol. 24:2003;751-765 IASP Press, Seattle.
32. McQuay H.G., Tramer M., Nye B.A.et al. A systematic review of anti-depressants in neuropathic pain. Pain. 68:1996;217-227.
33. Campbell F.G., Graham J.G., Zilkha K.J. Clinical trial of carbamazepine (Tegretol) in trigeminal neuralgia. J Neurol Neurosurg Psychiatry. 29:1966;265-267.
34. Rowbotham M., Harden N., Stacey B., Bernstein P., Magnus-Miller L. Gabapentin for the treatment of post-herpetic neuralgia: a randomized controlled trial. JAMA. 280:1998;1837-1842.
35. Backonja M., Beydoun A., Edwards K.R.et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. A randomized controlled trial. JAMA. 280:1998;1831-1836.
36. Serpell M.G. Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. Pain. 99:2002;557-566.
37. Bernstein J.E., Korman N.J., Bickers D.R., Dahl M.V., Millikan L.E. Topical capsaicin treatment of chronic post-herpetic neuralgia. J Am Acad Dermatol. 21:1989;265-270.
38. Group C.S. Treatment of painful diabetic neuropathy with topical capsaicin. A multi-centre, double-blind, vehicle-controlled study. Arch Intern Med. 151:1991;2225-2229.
39. Argoff C.E. New analgesics for neuropathic pain: the lidocaine patch. Clin J Pain. 16(suppl):2000;S62-S66.
40. Argoff C.E., Gimbel J., Hale M.et al. Effectiveness of lidocaine patch 5% (Lidoderm) in the treatment of low back pain. 10th World Congress on Pain, San Diego, CA. 2002;IASP Press, Seattle.